Skip to content

Edwards Lifesciences EW Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin312.9%-1.6pp314.6%-1.4pp316%-1.6pp317.6%-0.7pp318.3%-0.1pp
Operating margin92.3%-4.4pp96.7%-4.5pp101.2%-2.3pp103.5%-1.6pp105.1%-0.1pp
Net margin131.3%-58.3pp189.6%-59.1pp248.7%-54.9pp303.6%+44.7pp258.9%+48.1pp
Returns
Return on equity81.3%-37.8pp119%-39.6pp158.6%-37.5pp196.1%+24.8pp171.3%+26.9pp
Return on invested capital61%-4.1pp65.1%-4.7pp69.8%-4.1pp73.9%-3.0pp76.8%-1.3pp
Efficiency
Asset turnover1.9×0.0×1.9×0.0×1.9×0.0×1.9×-0.1×-0.1×
Liquidity
Current ratio16.8×0.0×16.9×-0.5×17.3×+0.5×16.8×+1.0×15.8×+0.7×
Leverage
Debt-to-equity0.3×0.0×0.3×0.0×0.3×0.0×0.3×0.0×0.3×0.0×
Net debt / EBITDA-5.6×+0.4×-6×0.0×-5.9×+0.6×-6.6×-1.0×-5.6×-1.2×
Per Share
Book value per share$70.79+0.8%$70.24+1.4%$69.28+2.2%$67.81+9.1%$62.18+9.6%
Valuation
Market capitalization$185.79B+2.0%$182.08B+3.3%$176.27B+3.5%$170.36B-6.2%$181.53B-7.7%
Price / earnings132.3×+32.0×100.3×+35.6×64.7×+23.8×40.9×-27.1×68×-30.5×
Price / sales31.1×-0.4×31.4×+0.1×31.3×+0.3×31×-2.9×33.9×-3.5×
Price / book17.9×+0.3×17.7×+0.4×17.3×+0.3×16.9×-3.3×20.2×-3.9×
EV / EBITDA116.2×+4.1×112.1×+6.3×105.7×+4.1×101.7×-8.8×110.4×-13.3×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Edwards Lifesciences's profit margins?
Edwards Lifesciences (EW) runs a 77.9% gross margin and a 21.4% operating margin, with a 17.4% net margin.
Where do Edwards Lifesciences's ratios come from?
Every ratio is computed from Edwards Lifesciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.